Cambridge, MA, United States of America

Neil Chandra Dalvie

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Massachusetts Institute of Technology. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Neil Chandra Dalvie. Retrieved from https://idiyas.com/inventor/neil-chandra-dalvie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Neil Chandra Dalvie: Innovator in Coronavirus Research

Introduction

Neil Chandra Dalvie is a prominent inventor based in Cambridge, MA, known for his significant contributions to the field of coronavirus research. He has developed innovative solutions aimed at combating viral infections, particularly those caused by SARS-CoV-2.

Latest Patents

Dalvie holds a patent for "SARS-CoV-2 antigens and uses thereof." This patent focuses on variants of the receptor binding domain of the coronavirus, which exhibit increased immunogenicity and reduced aggregation. The RBD variants are intended for use in methods that prevent infection by the coronavirus, showcasing Dalvie's commitment to advancing public health.

Career Highlights

Dalvie is affiliated with the Massachusetts Institute of Technology, where he engages in cutting-edge research. His work is instrumental in the ongoing fight against viral diseases, particularly in the context of the global pandemic.

Collaborations

Some of his notable coworkers include J Christopher Love and Sergio Andre Rodriguez Aponte, who collaborate with him on various research initiatives.

Conclusion

Neil Chandra Dalvie's innovative work in the field of coronavirus research exemplifies the critical role of inventors in addressing global health challenges. His contributions are vital in the ongoing efforts to develop effective strategies against viral infections.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…